Drug Profile
APB 101
Alternative Names: APB-101Latest Information Update: 27 Jun 2023
Price :
$50
*
At a glance
- Originator University of Massachusetts Medical School
- Developer Apic Bio
- Class Gene therapies; Hepatoprotectants
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Alpha 1-antitrypsin deficiency